← All trials
NCT05853601
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 17, 2023
- Primary completion
- Apr 1, 2026
- Completion date
- Apr 1, 2027
- First posted
- May 11, 2023
- Last posted
- Oct 19, 2023
- Enrollment
- 54
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Medical College of WisconsinLead sponsor
- Medical College of WisconsinOverall official - principal investigator
- Medical College of WisconsinReponsible party - principal investigator
- University of OklahomaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.